We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHH icon
101
Choice Hotels
CHH
$5.07B
$7.14M 0.09%
60,000
+12,204
+26% +$1.44M
BLTE
102
Belite Bio
BLTE
$6.36B
$6.76M 0.09%
+148,000
New +$6.41M
LEVI icon
103
Levi Strauss
LEVI
$9.44B
$6.69M 0.08%
+347,000
New +$7.6M
ASMB icon
104
Assembly Biosciences
ASMB
$498M
$6.42M 0.08%
+468,000
New +$6.67M
DNMR
105
DELISTED
Danimer Scientific, Inc.
DNMR
$6.29M 0.08%
260,600
+25,350
+11% +$788K
ELDN icon
106
Eledon Pharmaceuticals
ELDN
$261M
$6.17M 0.08%
2,336,000
+39,000
+2% +$93.1K
RHP icon
107
Ryman Hospitality Properties
RHP
$8.43B
$6M 0.08%
60,063
+35,319
+143% +$3.72M
CTXR icon
108
Citius Pharmaceuticals
CTXR
$15.6M
$5.93M 0.07%
+406,240
New +$7.28M
GB
109
DELISTED
Global Blue Group Holding
GB
$5.85M 0.07%
1,214,475
– –
RMTI icon
110
Rockwell Medical
RMTI
$28.4M
$5.67M 0.07%
322,164
+59,200
+23% +$1M
CKPT
111
DELISTED
Checkpoint Therapeutics
CKPT
$5.39M 0.07%
2,506,000
-210,000
-8% -$374K
MURA
112
DELISTED
Mural Oncology
MURA
$5.3M 0.07%
1,688,000
+30,000
+2% +$111K
ASO icon
113
Academy Sports + Outdoors
ASO
$2.94B
$5.09M 0.06%
95,627
-23,421
-20% -$1.33M
CBUS icon
114
Cibus
CBUS
$147M
$5.08M 0.06%
+516,000
New +$7.8M
ANGO icon
115
AngioDynamics
ANGO
$611M
$5.06M 0.06%
836,000
-36,000
-4% -$222K
SGMO
116
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.04M 0.06%
14,060,000
-2,898,477
-17% -$1.57M
W icon
117
Wayfair
W
$11.2B
$4.9M 0.06%
+93,000
New +$5.52M
WST icon
118
West Pharmaceutical
WST
$24B
$4.38M 0.06%
13,283
-2,694
-17% -$952K
GOOS
119
Canada Goose Holdings
GOOS
$872M
$4.33M 0.05%
+335,000
New +$4.16M
LEN icon
120
Lennar Class A
LEN
$19.8B
$4.25M 0.05%
29,326
-7,862
-21% -$1.2M
SDIG
121
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$3.93M 0.05%
915,978
-84,022
-8% -$283K
EOLS icon
122
Evolus
EOLS
$385M
$3.91M 0.05%
+360,000
New +$4.43M
CAVA icon
123
CAVA Group
CAVA
$7.6B
$3.9M 0.05%
42,096
+34,040
+423% +$2.63M
SIG icon
124
Signet Jewelers
SIG
$3.61B
$3.88M 0.05%
+43,267
New +$4.27M
VSXY
125
Victoria's Secret
VSXY
$7.05B
$3.87M 0.05%
219,000
-66,000
-23% -$1.26M
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.